Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

08 Oct 2020
Diabetes, hypertension, and older age are associated with lower hospital readmission in patients with gastroparesis, while higher length of stay (LOS), drug abuse, and marijuana use increase the 30-day readmission rate, a study has shown.

Low serum potassium, diabetes worsen cardiac outcomes in HFpEF

18 Sep 2020

The combination of diabetes and low serum potassium in heart failure patients with preserved ejection fraction (HFpEF) is tied to the risk of adverse outcomes, a recent study has found.

The study included 363 HFpEF patients (median age, 73.0 years; 70.3 percent female) who at baseline underwent a clinical examination, submaximal exercise testing, transthoracic echocardiography and other imaging procedures, and routine laboratory testing. The study outcome was a composite between HF hospitalization and/or cardiac death.

Over a median follow-up of 23.0 months, 114 endpoint events were reported, most of which (n=106) were HF hospitalizations. Only eight cardiac deaths were reported. Researchers found a threshold serum potassium concentration of 3.71 mmol/L, at or below which the risk of the composite endpoint was significantly elevated (hazard ratio [HR], 1.83, 95 percent confidence interval [CI], 1.14–2.94; p=0.0118).

Other independent predictors of the composite adverse outcome included a history of HF hospitalizations (HR, 2.77, 95 percent CI, 1.82–4.21; p<0.0001), higher log N-terminal pro-B-type natriuretic peptide (HR 1.93, 95 percent CI, 1.82–4.21; p=0.0084), and type 2 diabetes mellitus (HR, 1.57, 95 percent CI, 1.05–2.34; p=0.0027).

Further stratifying the participants according to type 2 diabetes status, the researchers found that the outcome was worst in those with diabetes and with serum potassium ≤3.71 mmol/L. Multivariate analysis showed that in this group, the risk of the combined endpoint was more than thrice that in patients without diabetes and with serum potassium >3.71 mmol/L.

Further studies are needed to determine whether serum potassium management, through supplementation or other therapies, may help improve cardiac outcomes in HFpEF patients.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

08 Oct 2020
Diabetes, hypertension, and older age are associated with lower hospital readmission in patients with gastroparesis, while higher length of stay (LOS), drug abuse, and marijuana use increase the 30-day readmission rate, a study has shown.